Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture

Sherry K. Pittman, Neilia G. Gracias, Michael Vasko, Jill Fehrenbacher

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Peripheral neuropathy (PN) is a debilitating and dose-limiting side effect of treatment with the chemotherapeutic agent, paclitaxel. Understanding the effects of paclitaxel on sensory neuronal function and the signaling pathways which mediate these paclitaxel-induced changes in function are critical for the development of therapies to prevent or alleviate the PN. The effects of long-term administration of paclitaxel on the function of sensory neurons grown in culture, using the release of the neuropeptide calcitonin gene-related peptide (CGRP) as an endpoint of sensory neuronal function, were examined. Dorsal root ganglion cultures were treated with low (10. nM) and high (300. nM) concentrations of paclitaxel for 1, 3, or 5. days. Following paclitaxel treatment, the release of CGRP was determined using capsaicin, a TRPV1 agonist; allyl isothiocyanate (AITC), a TRPA1 agonist; or high extracellular potassium. The effects of paclitaxel on the release of CGRP were stimulant-, concentration-, and time-dependent. When neurons were stimulated with capsaicin or AITC, a low concentration of paclitaxel (10. nM) augmented transmitter release, whereas a high concentration (300. nM) reduced transmitter release in a time-dependent manner; however, when high extracellular potassium was used as the evoking stimulus, all concentrations of paclitaxel augmented CGRP release from sensory neurons. These results suggest that paclitaxel alters the function of sensory neurons in vitro, and suggest that the mechanisms by which paclitaxel alters neuronal function may include functional changes in TRP channel activity. The described in vitro model will facilitate future studies to identify the signaling pathways by which paclitaxel alters neuronal sensitivity.

Original languageEnglish
Pages (from-to)146-153
Number of pages8
JournalExperimental Neurology
Volume253
DOIs
StatePublished - Mar 2014

Fingerprint

Calcitonin Gene-Related Peptide
Sensory Receptor Cells
Paclitaxel
Capsaicin
Peripheral Nervous System Diseases
Potassium
Spinal Ganglia
Neuropeptides
Therapeutics

Keywords

  • CGRP
  • Chemotherapy-induced peripheral neuropathy
  • Dorsal root ganglion culture
  • Neuropeptide release
  • Neurotoxicity
  • Paclitaxel
  • Peripheral sensory neuron
  • TRPA1
  • TRPV1

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture. / Pittman, Sherry K.; Gracias, Neilia G.; Vasko, Michael; Fehrenbacher, Jill.

In: Experimental Neurology, Vol. 253, 03.2014, p. 146-153.

Research output: Contribution to journalArticle

@article{7c2751f2db4f4162be43eb876c2d1eaf,
title = "Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture",
abstract = "Peripheral neuropathy (PN) is a debilitating and dose-limiting side effect of treatment with the chemotherapeutic agent, paclitaxel. Understanding the effects of paclitaxel on sensory neuronal function and the signaling pathways which mediate these paclitaxel-induced changes in function are critical for the development of therapies to prevent or alleviate the PN. The effects of long-term administration of paclitaxel on the function of sensory neurons grown in culture, using the release of the neuropeptide calcitonin gene-related peptide (CGRP) as an endpoint of sensory neuronal function, were examined. Dorsal root ganglion cultures were treated with low (10. nM) and high (300. nM) concentrations of paclitaxel for 1, 3, or 5. days. Following paclitaxel treatment, the release of CGRP was determined using capsaicin, a TRPV1 agonist; allyl isothiocyanate (AITC), a TRPA1 agonist; or high extracellular potassium. The effects of paclitaxel on the release of CGRP were stimulant-, concentration-, and time-dependent. When neurons were stimulated with capsaicin or AITC, a low concentration of paclitaxel (10. nM) augmented transmitter release, whereas a high concentration (300. nM) reduced transmitter release in a time-dependent manner; however, when high extracellular potassium was used as the evoking stimulus, all concentrations of paclitaxel augmented CGRP release from sensory neurons. These results suggest that paclitaxel alters the function of sensory neurons in vitro, and suggest that the mechanisms by which paclitaxel alters neuronal function may include functional changes in TRP channel activity. The described in vitro model will facilitate future studies to identify the signaling pathways by which paclitaxel alters neuronal sensitivity.",
keywords = "CGRP, Chemotherapy-induced peripheral neuropathy, Dorsal root ganglion culture, Neuropeptide release, Neurotoxicity, Paclitaxel, Peripheral sensory neuron, TRPA1, TRPV1",
author = "Pittman, {Sherry K.} and Gracias, {Neilia G.} and Michael Vasko and Jill Fehrenbacher",
year = "2014",
month = "3",
doi = "10.1016/j.expneurol.2013.12.011",
language = "English",
volume = "253",
pages = "146--153",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture

AU - Pittman, Sherry K.

AU - Gracias, Neilia G.

AU - Vasko, Michael

AU - Fehrenbacher, Jill

PY - 2014/3

Y1 - 2014/3

N2 - Peripheral neuropathy (PN) is a debilitating and dose-limiting side effect of treatment with the chemotherapeutic agent, paclitaxel. Understanding the effects of paclitaxel on sensory neuronal function and the signaling pathways which mediate these paclitaxel-induced changes in function are critical for the development of therapies to prevent or alleviate the PN. The effects of long-term administration of paclitaxel on the function of sensory neurons grown in culture, using the release of the neuropeptide calcitonin gene-related peptide (CGRP) as an endpoint of sensory neuronal function, were examined. Dorsal root ganglion cultures were treated with low (10. nM) and high (300. nM) concentrations of paclitaxel for 1, 3, or 5. days. Following paclitaxel treatment, the release of CGRP was determined using capsaicin, a TRPV1 agonist; allyl isothiocyanate (AITC), a TRPA1 agonist; or high extracellular potassium. The effects of paclitaxel on the release of CGRP were stimulant-, concentration-, and time-dependent. When neurons were stimulated with capsaicin or AITC, a low concentration of paclitaxel (10. nM) augmented transmitter release, whereas a high concentration (300. nM) reduced transmitter release in a time-dependent manner; however, when high extracellular potassium was used as the evoking stimulus, all concentrations of paclitaxel augmented CGRP release from sensory neurons. These results suggest that paclitaxel alters the function of sensory neurons in vitro, and suggest that the mechanisms by which paclitaxel alters neuronal function may include functional changes in TRP channel activity. The described in vitro model will facilitate future studies to identify the signaling pathways by which paclitaxel alters neuronal sensitivity.

AB - Peripheral neuropathy (PN) is a debilitating and dose-limiting side effect of treatment with the chemotherapeutic agent, paclitaxel. Understanding the effects of paclitaxel on sensory neuronal function and the signaling pathways which mediate these paclitaxel-induced changes in function are critical for the development of therapies to prevent or alleviate the PN. The effects of long-term administration of paclitaxel on the function of sensory neurons grown in culture, using the release of the neuropeptide calcitonin gene-related peptide (CGRP) as an endpoint of sensory neuronal function, were examined. Dorsal root ganglion cultures were treated with low (10. nM) and high (300. nM) concentrations of paclitaxel for 1, 3, or 5. days. Following paclitaxel treatment, the release of CGRP was determined using capsaicin, a TRPV1 agonist; allyl isothiocyanate (AITC), a TRPA1 agonist; or high extracellular potassium. The effects of paclitaxel on the release of CGRP were stimulant-, concentration-, and time-dependent. When neurons were stimulated with capsaicin or AITC, a low concentration of paclitaxel (10. nM) augmented transmitter release, whereas a high concentration (300. nM) reduced transmitter release in a time-dependent manner; however, when high extracellular potassium was used as the evoking stimulus, all concentrations of paclitaxel augmented CGRP release from sensory neurons. These results suggest that paclitaxel alters the function of sensory neurons in vitro, and suggest that the mechanisms by which paclitaxel alters neuronal function may include functional changes in TRP channel activity. The described in vitro model will facilitate future studies to identify the signaling pathways by which paclitaxel alters neuronal sensitivity.

KW - CGRP

KW - Chemotherapy-induced peripheral neuropathy

KW - Dorsal root ganglion culture

KW - Neuropeptide release

KW - Neurotoxicity

KW - Paclitaxel

KW - Peripheral sensory neuron

KW - TRPA1

KW - TRPV1

UR - http://www.scopus.com/inward/record.url?scp=84892532747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892532747&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2013.12.011

DO - 10.1016/j.expneurol.2013.12.011

M3 - Article

C2 - 24374060

AN - SCOPUS:84892532747

VL - 253

SP - 146

EP - 153

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

ER -